
Medibank Private Ltd
ASX:MPL

Intrinsic Value
The intrinsic value of one
MPL
stock under the Base Case scenario is
4.64
AUD.
Compared to the current market price of 4.9 AUD,
Medibank Private Ltd
is
Overvalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medibank Private Ltd
Fundamental Analysis

Medibank’s costly and high-profile 2022 data breach may erode consumer trust in its brand, creating potential churn and putting downward pressure on membership growth.
Medibank’s dominant market share and strong brand recognition position it to capture ongoing industry tailwinds, such as an aging population seeking private health coverage.

Balance Sheet Decomposition
Medibank Private Ltd
Cash & Short-Term Investments | 454m |
Insurance Receivable | 46.4m |
PP&E | 196.4m |
Long-Term Investments | 2.9B |
Other Assets | 569.3m |
Wall St
Price Targets
MPL Price Targets Summary
Medibank Private Ltd
According to Wall Street analysts, the average 1-year price target for
MPL
is 4.77 AUD
with a low forecast of 4.29 AUD and a high forecast of 5.36 AUD.
Dividends
Current shareholder yield for MPL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MPL
stock under the Base Case scenario is
4.64
AUD.
Compared to the current market price of 4.9 AUD,
Medibank Private Ltd
is
Overvalued by 5%.